Atópiás dermatitisz (ekcéma): vizsgálatok itt: Ausztrália
11 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 1. fázisTaking peopleA Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis
- Where
- Carlton, Woolloongabba
- Életkor
- 18 év to 65 év
- People
- 84 worldwide
- Run by
- Zai Lab (Shanghai) Co., Ltd.
See details and how to joinNCT07235384 - 1. fázisNot yet taking people in AusztráliaA Study of NOR-101 in Healthy Adults and Adults With Moderate-to-Severe Atopic Dermatitis
- Where
- Adelaide
- Életkor
- 18 év to 65 év
- People
- 96
- Run by
- North Immunology Inc.
See details and how to joinNCT07904689 - 1. fázisTaking peoplePhase 1a/1b Study of TRB-061 in Healthy Participants & Patients With Atopic Dermatitis
- Where
- Adelaide, Albion, Blacktown, Coorparoo, Deakin, Kanwal, Melbourne, Saint Albans
- Életkor
- 18 év to 70 év
- People
- 115 worldwide
- Run by
- TRex Bio, Inc.
See details and how to joinNCT06934252 - 2. fázisTaking peoplePRA-216 Atopic Dermatitis Safety and Efficacy Study
- Where
- Botany, Camberwell, Coorparoo, Liverpool, Melbourne
- Életkor
- 18 év to 70 év
- People
- 39 worldwide
- Run by
- Prana Therapies Inc
See details and how to joinNCT07810777 - 3. fázisCsak meghívásosA Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
- Where
- Coorparoo, Randwick, Westmead, Woolloongabba
- Életkor
- 6 hónap to 18 év
- People
- 338 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT05735483 · EU 2022-501478-21-00 - 2. fázisNot yet taking people in AusztráliaTo Evaluate the Safety and Efficacy of Hemay5394 in Patients With Mild to Moderate Atopic Dermatitis
- Where
- Waitara
- Életkor
- 18 év to 75 év
- People
- 90
- Run by
- Hemay Pharmaceutical PTY. LTD.
See details and how to joinNCT07877155 - 1. fázisTaking peopleA Study of BYN-001 in Healthy Adults and in Adults With Moderate to Severe Atopic Dermatitis
- Where
- Melbourne
- Életkor
- 18 év to 55 év
- People
- 56
- Run by
- Bionyra Pharma
See details and how to joinNCT07746817 - 1. fázisTaking peopleA Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
- Where
- Fremantle, Perth
- Életkor
- 18 év to 72 év
- People
- 237 worldwide
- Run by
- Bambusa Therapeutics
See details and how to joinNCT06808477 · EU 2025-522918-23-00 - 2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Where
- Benowa, Carlton, Liverpool, Mitcham, Woden
- Életkor
- 18 év to 74 év
- People
- 405 worldwide
- Run by
- Inmagene LLC
See details and how to joinNCT07037901 · EU 2024-520117-50-00 - 1. fázisTaking peopleStudy of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
- Where
- Birtinya, Charlestown
- Életkor
- 18 év to 75 év
- People
- 24
- Run by
- Seismic Therapeutic AU Pty Ltd
See details and how to joinNCT07455578 - 2. fázisTaking peoplePhase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.
- Where
- Benowa, Brookvale, Darlinghurst, Kogarah, Kotara, Nedlands, North Altona, Waitara, Wellers Hill, Wollongong, Woolloongabba
- Életkor
- 2 év and over
- People
- 72
- Run by
- Alphyn Biologics
See details and how to joinNCT06855745